Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1–Parkin pathway and modulate cellular drug response
Conggang Zhang(University of Colorado Boulder), Xuedong Liu(University of Colorado Boulder)
Cited by 104
Related Papers
Absent expression of miR‑30a promotes the growth of lung cancer cells by targeting MEF2D
|Oncology Letters|2018|20
BL-918 activates PINK1/Parkin signaling pathway to ameliorate the progression of Parkinson’s disease
|Journal of Biological Chemistry|2024|16